1. Home
  2. Southern Africa
  3. South Africa

Thousands of dollars for HIV vaccine initiative

The South African AIDS Vaccine Initiative (SAAVI) is set to benefit from a pledge of almost US $590,000 made by two of the country's largest employers.

According to a recent SAAVI statement, research and development of an effective HIV/AIDS vaccine will receive around $369,000 over five years from Impala Platinum Holdings, while the transport parastatal, Transnet, had donated about $222,000.

The first of several human trials of an HIV vaccine to be conducted in the country were announced by SAAVI in November 2003.

The donations were welcomed by SAAVI director Dr Tim Tucker, who said: "HIV vaccine research and development is an expensive, long-term undertaking, and will require ongoing support and partnerships such as this from all sectors to be successful."


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join